Physician and patient perception of adjustable maintenance dosing of Symbicort Turbuhaler - REALITY

Exclusion Criteria

• - Asthma exacerbation requiring oral corticosteroid treatment in the four weeks prior to visit 1
• - Upper Respiratory Tract Infection in the previous four weeks
• - Severe cardiovascular disease or other significant concomitant disease, which may interfere with the conduct of the study.
• - Women enrolled in the trial should not be planning pregnancy and should be taking adequate contraceptive measures where appropriate.
• - Previous enrollment in a clinical study
• - Known or suspected hypersensitivity to budesonide, formoterol or inhaled lactose